For those of us working in primary care, medicines supply problems are no longer occasional disruptions. They are a constant operational pressure, shaping how pharmacies function, how prescribers work, and how patients experience the system.

What continues to concern me is not that medicines go short, but how late the system formally acknowledges that something is wrong.

This is something many of us in community pharmacy are actively trying to change. Across local and regional networks, we are working to raise the profile of medicines stock issues, not to create alarm, but to ensure the realities on the ground are better understood earlier and acted on more effectively.

By the time an “official” update appears, community pharmacies have often been dealing with the issue for weeks or even months. Stock has been difficult to source, prices have started to move sharply, and teams have already absorbed the workload of chasing suppliers, contacting practices, and managing patient frustration.

At that point, the problem is no longer emerging. It is already embedded.

Why pharmacies no longer hold buffer stock

It is often asked why pharmacies don’t simply hold more stock to protect against supply disruption. On the surface, that sounds reasonable. In practice, it no longer reflects the financial reality of community pharmacy.

Pharmacies operate in an environment of:

  • highly volatile acquisition prices

  • uncertain and delayed reimbursement

  • increasing frequency of price concessions

  • limited working capital

Holding large quantities of stock now carries real financial risk. A medicine bought at a peak price can quickly become loss-making if reimbursement shifts or prices correct. For many pharmacies, especially independents, that risk is not theoretical, it directly threatens viability.

As a result, pharmacies have been forced to run leaner inventories. This is not about poor planning or short-term thinking. It is a rational response to a volatile and financially exposed system.

How risk reduction can unintentionally increase fragility

The consequence of this necessary risk management is that when a genuine supply issue emerges, there is less buffer in the system.

Without stock held locally:

  • disruption is felt more immediately

  • ordering becomes more competitive

  • price volatility accelerates

  • workload spikes across pharmacies and GP practices

This is not caused by hoarding or panic. It is the cumulative effect of thousands of pharmacies sensibly trying to limit financial exposure in a volatile market.

In other words, behaviour that protects individual pharmacies day-to-day can inadvertently make the wider system more sensitive when supply tightens.

When information arrives too late to be useful

Much of the official supply information available in England is designed for governance and safety, not early operational planning. That has a purpose, but it also creates a visibility gap.

When national updates finally appear, they tend to confirm what frontline teams already know — not help them prepare. By that stage:

  • pharmacies have already been firefighting

  • prescribers have already been disrupted

  • patients have already experienced delays and confusion

The system is no longer choosing between options. It is managing consequences.

Earlier visibility doesn’t remove financial risk, but it allows pharmacies and system partners to manage it more deliberately — rather than react under pressure.

Early visibility is not the same as panic buying

One concern that often comes up is whether earlier access to supply information would encourage stockpiling. In my experience, that misunderstands how community pharmacy actually works.

Pharmacies don’t benefit from hoarding medicines they cannot safely manage or afford to carry. What they benefit from is certainty.

Knowing that a medicine is likely to become problematic allows teams to:

  • adjust ordering patterns proportionately

  • avoid last-minute high-cost purchases

  • communicate earlier with GP practices

  • manage patient expectations more honestly

Other healthcare systems operate with earlier supply alerts as standard, and they don’t descend into chaos. They operate with greater professionalism and less volatility.

Data doesn’t create shortages. Late data magnifies their impact.

The cost we don’t always measure

One of the most overlooked consequences of supply disruption in primary care is avoidable workload.

Every time a prescription can’t be sourced, time is lost:

  • contacting suppliers

  • calling practices

  • reissuing prescriptions

  • explaining delays to patients

None of this is clinical care, yet it consumes clinical capacity in a system already under pressure. Over time, that erosion matters — to staff morale, patient trust, and sustainability.

Moving from reaction to preparedness

Supply disruption isn’t going away. Global manufacturing concentration, international demand shifts, and pricing pressure make that clear.

The real question for primary care is not whether shortages will happen, but how prepared we are when they do.

Earlier, better-connected supply intelligence won’t eliminate risk. But it can change the point at which the system starts responding — from late-stage crisis management to earlier, more controlled action.

For community pharmacy and primary care more broadly, that shift isn’t a luxury. It’s becoming essential if we want to protect financial viability, professional capacity, and patient care in an increasingly fragile environment.

About the author:

Adeel Sarwar is the Vice Chair of CPWY and has owned, managed and been director of several pharmacies in Leeds and Bradford since 2004.